anidulafungin has been researched along with Hepatic Insufficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellanger, AP; Cervoni, JP; Deconinck, E; Faucher, JF; Ginet, M; Grenouillet, F; Weil-Verhoeven, D | 1 |
| Damle, B; Dowell, JA; Krause, D; Stogniew, M | 1 |
1 trial(s) available for anidulafungin and Hepatic Insufficiency
| Article | Year |
|---|---|
Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment.
Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Area Under Curve; Echinocandins; Female; Half-Life; Hepatic Insufficiency; Humans; Male; Metabolic Clearance Rate; Middle Aged; Peptides, Cyclic; Renal Insufficiency | 2007 |
1 other study(ies) available for anidulafungin and Hepatic Insufficiency
| Article | Year |
|---|---|
Paecilomyces variotii Fungemia in a Patient with Lymphoma Needing Liver Transplant.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Echinocandins; Fungemia; Hepatic Insufficiency; Humans; Liver Transplantation; Lymphoma; Male; Middle Aged; Paecilomyces | 2017 |